Loading…
Attending this event?
View analytic
Tuesday, June 20 • 10:30am - 11:45am
#216: International Collaboration in Times of Public Health Crisis

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

International collaboration amongst regulators is important from the industry aspiration that it should suffice to develop one global dossier. In the wake of the Ebola crisis, and again during the current Zika event, regulators have and are demonstrating a willingness to find new and pragmatic ways of working together with industry with the ultimate goal of providing health care solutions which are in demand by society. Are there lessons learned that can be shared and discussed? Can the envelope be pushed even further?

Learning Objectives

Describe the current state of cooperation amongst regulators during Public Health Emergencies; Identify the challenges faced by the stakeholders, Discuss lessons learned in addressing the challenges.

Chair

Ian Hudson

Speaker

Crisis Management in the Face of a Global Health Pandemic: How Can We Leverage International Efforts?
Jarbas Barbosa

Update From the FDA
Carmen T. Maher

Update from the EMA
Agnès Saint-Raymond, MD



Moderators
avatar for Ian Hudson

Ian Hudson

Chief Executive, Medicines and Healthcare products Regulatory Agency (MHRA)
Dr Ian Hudson became Chief Executive of the MHRA in September 2013. He is a physician who practiced as a paediatrician prior to working in the pharmaceutical industry in clinical research and development. In 2001 he joined the former Medicines Control Agency as its Licencing Divi... Read More →

Speakers
avatar for Jarbas Barbosa

Jarbas Barbosa

ICMRA Project Lead; Director- President, Agência Nacional De Vigilância Sanitária (ANVISA)
Jarbas Barbosa da Silva Jr. is a public health physician and epidemiologist, with national and international experience in public health, epidemiology applied to health services, health surveillance, prevention and control of diseases and illnesses, and management of health syste... Read More →
avatar for Ian Hudson

Ian Hudson

Chief Executive, Medicines and Healthcare products Regulatory Agency (MHRA)
Dr Ian Hudson became Chief Executive of the MHRA in September 2013. He is a physician who practiced as a paediatrician prior to working in the pharmaceutical industry in clinical research and development. In 2001 he joined the former Medicines Control Agency as its Licencing Divi... Read More →
avatar for Carmen Maher

Carmen Maher

Acting Assistant Commissioner for Counterterrorism Policy, OCS, OC, FDA
RADM Carmen Maher, MA, BSN, RN, RAC, is a nurse officer in the U.S. Public Health Service Commissioned Corps. She is an Assistant Surgeon General and Acting Assistant Commissioner for Counterterrorism Policy and Acting Director of the Office of Counterterrorism and Emerging Threa... Read More →
avatar for Agnès Saint-Raymond

Agnès Saint-Raymond

Head of International Affairs (ad interim), Head of Portfolio Board, European Medicines Agency, European Union
MD and qualified Paediatrician. Chef de Clinique in Paed. in Necker-Enfants-Malades Hospital (Paris, 1985-1990). Joined French Agency for medicines (now ANSM) in 1995 as Head of a Pharmaco-Toxico-Clinical Assessment Unit. Joined EMA in 2000. Head of Special Areas for Human Medici... Read More →


Tuesday June 20, 2017 10:30am - 11:45am
N229 McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616